Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Heem Wong

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biostatistics (Oxford, England)|February 3, 2018
Estimation of clinical trial success rates and related parametersChi Heem Wong, Kien Wei Siah, Andrew W Lo
PLOS Global Public Health|March 24, 2023
Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?Zied Ben Chaouch, Andrew W Lo, Chi Heem Wong
Biostatistics (Oxford, England)|November 17, 2018
Corrigendum: Estimation of clinical trial success rates and related parametersChi Heem Wong, Kien Wei Siah, Andrew W Lo
Journal of Multimorbidity and Comorbidity|June 7, 2022
Multimorbidity and mortality: A data science perspectiveKien Wei Siah, Chi Heem Wong, Jerry Gupta, et al.
JCO Clinical Cancer Informatics|September 21, 2019
Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung CancerKien Wei Siah, Sean Khozin, Chi Heem Wong, et al.
Contemporary Clinical Trials Communications|April 18, 2025
Predicting clinical trial duration via statistical and machine learning modelsJoonhyuk Cho, Qingyang Xu, Chi Heem Wong, et al.
Anesthesiology|May 3, 2022
Estimates of Probabilities of Successful Development of Pain Medications: An Analysis of Pharmaceutical Clinical Development Programs from 2000 to 2020Dermot P Maher, Chi Heem Wong, Kien Wei Siah, et al.
Gene Therapy|November 7, 2023
The estimated annual financial impact of gene therapy in the United StatesChi Heem Wong, Dexin Li, Nina Wang, et al.
Nature Biotechnology|December 9, 2017
Just how good an investment is the biopharmaceutical sector?Richard T Thakor, Nicholas Anaya, Yuwei Zhang, et al.
Plos One|December 28, 2020
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidatesDonald A Berry, Scott Berry, Peter Hale, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biostatistics (Oxford, England)|February 3, 2018
Estimation of clinical trial success rates and related parametersChi Heem Wong, Kien Wei Siah, Andrew W Lo
PLOS Global Public Health|March 24, 2023
Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?Zied Ben Chaouch, Andrew W Lo, Chi Heem Wong
Biostatistics (Oxford, England)|November 17, 2018
Corrigendum: Estimation of clinical trial success rates and related parametersChi Heem Wong, Kien Wei Siah, Andrew W Lo
Journal of Multimorbidity and Comorbidity|June 7, 2022
Multimorbidity and mortality: A data science perspectiveKien Wei Siah, Chi Heem Wong, Jerry Gupta, et al.
JCO Clinical Cancer Informatics|September 21, 2019
Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung CancerKien Wei Siah, Sean Khozin, Chi Heem Wong, et al.
Contemporary Clinical Trials Communications|April 18, 2025
Predicting clinical trial duration via statistical and machine learning modelsJoonhyuk Cho, Qingyang Xu, Chi Heem Wong, et al.
Anesthesiology|May 3, 2022
Estimates of Probabilities of Successful Development of Pain Medications: An Analysis of Pharmaceutical Clinical Development Programs from 2000 to 2020Dermot P Maher, Chi Heem Wong, Kien Wei Siah, et al.
Gene Therapy|November 7, 2023
The estimated annual financial impact of gene therapy in the United StatesChi Heem Wong, Dexin Li, Nina Wang, et al.
Nature Biotechnology|December 9, 2017
Just how good an investment is the biopharmaceutical sector?Richard T Thakor, Nicholas Anaya, Yuwei Zhang, et al.
Plos One|December 28, 2020
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidatesDonald A Berry, Scott Berry, Peter Hale, et al.
Pageof 1